New York, June 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global qPCR and dPCR Instrumentation Industry" - In traditional Polymerase Chain Reaction (PCR), the amplified DNA product or amplicon is detected in an end-point analysis by visualization of the DNA product on an agarose gel subsequent to completion of the reaction, which comprises a specified number of amplification cycles. In real-time PCR, however, the accumulation of amplification product is evaluated simultaneously with the progress of the reaction. Product quantification is carried out in real time, after every cycle. Digital PCR (dPCR) is an improvement of traditional PCR methods and is utilized to directly quantify as well as clonally amplify nucleic acids such as DNA, RNA, cDNA or methylated DNA. However, digital PCR is at an early stage. The main difference between conventional PCR and dPCR lies in the method used to measure amounts of nucleic acids. Sensitivity of dPCR is high in comparison to qPCR, hence, the technology is particularly used in applications wherein there is a low amount of target sequence. For instance, mutation genes that are found on a very low scale in rare diseases, and HIV DNA that are present in 1,000-10,000 in number within the cell of a patient can be easily detected through the technology. - Amid the COVID-19 crisis, the global market for qPCR and dPCR Instrumentation estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2026, growing at a CAGR of 9.8% over the analysis period. qPCR, one of the segments analyzed in the report, is projected to grow at a 9.3% CAGR to reach US$8.4 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the dPCR segment is readjusted to a revised 13% CAGR for the next 7-year period. This segment currently accounts for a 12.5% share of the global qPCR and dPCR Instrumentation market. The U.S. Market is Estimated at $1.9 Billion in 2021, While China is Forecast to Reach $742.3 Million by 2026 - The qPCR and dPCR Instrumentation market in the U.S. is estimated at US$1.9 Billion in the year 2021. The country currently accounts for a 30.8% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$742.3 Million in the year 2026 trailing a CAGR of 12.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR while Rest of European market (as defined in the study) will reach US$813.9 Million by the close of the analysis period. - While Europe is another large market for qPCR and dPCR instrumentation, growth worldwide is projected to be spearheaded by Asia-Pacific. In terms of concentration, a large number of leading companies are located in the US and Europe. However, increasing competition in the markets over the last few years has been driving various players to shift their attention to other promising regions including Latin America and Asia-Pacific. In Asia-Pacific, growth is led by the increased use of qPCR in blood donor testing & screening and diagnosis of infectious diseases and tropical diseases such as Malaria. Increasing geriatric population and the resulting incidents of chronic medical conditions such as cancer coupled with broader application of PCR to study mutations and gene anomalies related to these diseases are driving adoption. Falling cost of nucleic acid detection, quantification, and amplification techniques will additionally encourage adoption of qPCR and dPCR instrumentation in research and diagnosis, particularly in developing, resource poor countries. Asia-Pacific has been witnessing increasing focus of PCR solution suppliers to establish or expand their production and sales network in the region. In the recent years, various vendors have shifted their manufacturing units to the region for enjoying cost benefits and accessing domestic markets, which in turn is increasing awareness of the technology in the region, contributing to growth in the market. Select Competitors (Total 74 Featured)
Read the full report: CONTENTS I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification Impact of Covid-19 and a Looming Global Recession 2020 Marked as a Year of Disruption & Transformation EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022 Impact of COVID-19 on Clinical Diagnostics Sector Emergence of PCR as a Preferred COVID-19 Detection Method Performance Analysis of COVID-19 Tests EXHIBIT 2: Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As of January 13th, 2021 Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market EXHIBIT 3: Global COVID-19 Testing Market Breakdown by Testing Type: 2020 and 2027 Select Approved Covid-19 Molecular Assay Tests Recent PCR Based Tests Digital PCR Sparks Increasing Interest High-Speed NanoPCR Technology Developed for Point-of-Care Diagnosis of COVID-19 CRISPR Emerges as Cutting-Edge Biotechnology in COVID-19 Diagnostic Market Demand for PCR Testing to Remain Buoyant in 2021 Real-Time PCR and Digital PCR: Scope and Definition Real-Time PCR or Quantitative PCR (qPCR) qPCR Instrumentation Disadvantages Advantages of qPCR End-Use Applications of qPCR Digital PCR (dPCR) Working Principle Applications of dPCR Advantages of dPCR qPCR Remains the Mainstay Technology Digital PCR to Experience Strong Growth High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR Developing Countries Drive Growth Opportunities Competition Competitive Factors Accelerated Commercialization of Products Manufacturers Step-Up Online Exposure Targeted Expansion of Distribution Reach and Global Footprint Recent Market Activity 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS Striking the Right Balance between qPCR and dPCR in Research Laboratories qPCR: A Suitable Tool for Gene Expression and Validation Digital PCR Takes Quantification of Nucleic Acids to the Next Level dPCR: A Valuable Tool in Virology Research Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR EXHIBIT 4: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 EXHIBIT 5: Breakdown of Total Number of Cancer Cases by Region: 2020 EXHIBIT 6: Breakdown of Total Number of Cancer Cases by Type: 2020 dPCR for Analyzing Hematologic Malignancies dPCR for Liquid Biopsies Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter EXHIBIT 7: Global Prenatal Diagnostics Market in US$ Billion: 2015 and 2022 EXHIBIT 8: Global Genetic Testing Market in US$ Billion: 2020 and 2027 Rise in Infectious Diseases Drives Opportunities for Biochips EXHIBIT 9: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %) EXHIBIT 10: Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %) Innovations in Instrumentation Expand Functionality and Drive Adoption Advancements in Probe Technology Enhance qPCR Sensitivity qPCR Market to Witness Increasing Affinity for Automated and Robotic Equipment Lab on Chip/Microfluidic Real-time-PCR Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years ddPCR: The More Advanced Digital Approach to dPCR ddPCR Gains Traction in Cancer Diagnosis Monitoring Disease Progression in HIV Studies EXHIBIT 11: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018 Analysis of Genetically Modified Organisms in Edible Products RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples Technology Advancements Aid in Overcoming Barriers Alternate Technologies Pose Threat to Growth of PCR Market Next-Generation Sequencing to Emerge as Novel Technique in Fight with COVID-19 Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests EXHIBIT 12: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 PCR in Forensic and Paternity Testing 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for qPCR and dPCR Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for qPCR by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for dPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for dPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for dPCR by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 22: World Current & Future Analysis for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Research Laboratories & Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 25: World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 26: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 28: World Current & Future Analysis for Clinical Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 29: World Historic Review for Clinical Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: World 15-Year Perspective for Clinical Research Organizations by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 31: World Current & Future Analysis for Forensic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 32: World Historic Review for Forensic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: World 15-Year Perspective for Forensic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 III. MARKET ANALYSIS UNITED STATES Table 34: USA Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 35: USA Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: USA 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027 Table 37: USA Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: USA Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: USA 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027 Table 40: USA Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: USA Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: USA 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027 CANADA Table 43: Canada Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: Canada Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: Canada 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027 Table 46: Canada Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: Canada Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: Canada 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027 Table 49: Canada Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Canada Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: Canada 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027 JAPAN Table 52: Japan Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: Japan Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Japan 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027 Table 55: Japan Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Japan Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Japan 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027 Table 58: Japan Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: Japan Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: Japan 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027 CHINA Table 61: China Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: China Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: China 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027 Table 64: China Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: China Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: China 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027 Table 67: China Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: China Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: China 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027 EUROPE Table 70: Europe Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 71: Europe Historic Review for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 73: Europe Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: Europe Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027 Table 76: Europe Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: Europe Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027 Table 79: Europe Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: Europe Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027 FRANCE Table 82: France Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: France Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: France 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027 Table 85: France Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: France Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: France 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027 Table 88: France Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: France Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: France 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027 GERMANY Table 91: Germany Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Read the full report: ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________